reglab/housing_qa huggingface dataset:
NV Rev Stat § 639.253 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.253 - Order following rehearing.

  1. On conclusion of the rehearing the Board may reaffirm the order previously adopted, or if new evidence is presented which controverts, in whole or in part, the allegations on which the accusation was based and if the Board considers that such action would be in the public interest, the Board may reset or reduce the penalty ordered at the conclusion of the original hearing.  2. The Board shall make, enter and file its order at the conclusion of the rehearing, or as soon thereafter as practicable, and cause a copy thereof to be served on the respondent and the respondent’s attorney of record within 30 days. The order shall not become effective until 30 days after receipt thereof by the respondent unless otherwise ordered by the Board.  (Added to NRS by 1967, 1660)
NV Rev Stat § 639.2535 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.2535 - Judicial review.

  1. Every order of the Board which limits the practice of pharmacy or any privileges extended by any certificate, permit, registration or license is effective until the date the order is modified or reversed by a final judgment of the reviewing court.  2. The district court shall give a petition for judicial review of the Board’s order priority over other civil matters which are not expressly given priority by law.  (Added to NRS by 1985, 875; A 1989, 1658)
NV Rev Stat § 639.255 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.255 - Authorized disciplinary action; judicial review of such action; fines; private reprimands prohibited; orders imposing discipline deemed public records.

  1. The holder of any certificate, license or permit issued by the Board, whose default has been entered or who has been heard by the Board and found guilty of the violations alleged in the accusation, may be disciplined by the Board by one or more of the following methods:  (a) Suspending judgment;  (b) Placing the certificate, license or permit holder on probation;  (c) Suspending the right of a certificate holder to practice, or the right to use any license or permit, for a period to be determined by the Board;  (d) Revoking the certificate, license or permit;  (e) Public reprimand; or  (f) Imposition of a fine for each count of the accusation, in accordance with the schedule of fines established pursuant to subsection 3.  2. Such action by the Board is final, except that the propriety of such action is subject to review upon questions of law by a court of competent jurisdiction.  3. The Board shall, by regulation, establish a schedule of fines that may be imposed pursuant to paragraph (f) of subsection 1. Each fine must be commensurate with the severity of the applicable violation, but must not exceed $10,000 for each violation.  4. The Board shall not issue a private reprimand.  5. An order that imposes discipline and the findings of fact and conclusions of law supporting that order are public records.  (Added to NRS by 1967, 1661; A 1973, 782; 1979, 1694; 1993, 888; 2001, 836, 1634; 2003, 3455)
NV Rev Stat § 639.2555 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.2555 - Suspension of certificate or license for failure to pay child support or comply with certain subpoenas or warrants; reinstatement of certificate or license. [Effective until 2 years after the date of the repeal of 42 U.S.C. § 666, the federal law requiring each state to establish procedures for withholding, suspending and restricting the professional, occupational and recreational licenses for child support arrearages and for noncompliance with certain processes relating to paternity or child support proceedings.]

  1. If the Board receives a copy of a court order issued pursuant to NRS 425.540 that provides for the suspension of all professional, occupational and recreational licenses, certificates and permits issued to a person who is the holder of a certificate of registration as a pharmacist, intern pharmacist, pharmaceutical technician or pharmaceutical technician in training or a license issued pursuant to NRS 639.233, the Board shall deem the certificate of registration or license issued to that person to be suspended at the end of the 30th day after the date on which the court order was issued unless the Board receives a letter issued to the holder of the certificate of registration or license by the district attorney or other public agency pursuant to NRS 425.550 stating that the holder of the certificate of registration or license has complied with the subpoena or warrant or has satisfied the arrearage pursuant to NRS 425.560.  2. The Board shall reinstate a certificate of registration as a pharmacist, intern pharmacist, pharmaceutical technician or pharmaceutical technician in training or a license issued pursuant to NRS 639.233 that has been suspended by a district court pursuant to NRS 425.540 if the Board receives a letter issued by the district attorney or other public agency pursuant to NRS 425.550 to the person whose certificate of registration or license was suspended stating that the person whose certificate of registration or license was suspended has complied with the subpoena or warrant or has satisfied the arrearage pursuant to NRS 425.560.  (Added to NRS by 1997, 2148; A 2003, 2293; 2005, 2807)
NV Rev Stat § 639.256 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.256 - Automatic restoration of certificate, license or permit suspended for a specified period.

A certificate, license or permit which has been suspended for a specified period of time must automatically be restored to good standing on the first day following the period of suspension. The Executive Secretary of the Board, when notifying the respondent of the penalty imposed by the Board, shall inform the respondent of the date on which the certificate, license or permit will be so restored.  (Added to NRS by 1967, 1661; A 2003, 2293)
NV Rev Stat § 639.2565 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.2565 - Reinstatement of suspended certificate.

  1. A person whose certificate has been suspended by the Board may petition the Board for reinstatement of the certificate.  2. After receipt of the petition, the Board shall conduct a hearing to determine whether the certificate should be reinstated.  3. If a hearing is held, the Board may consider the results of its own investigation and any evidence pertaining to the competence of the petitioner. An affirmative vote of a majority of Board members is necessary to reinstate a certificate. The Board may require, prior to reinstatement, that the petitioner pass an examination, either oral or written, to determine the petitioner’s present fitness to resume practice.  4. In any hearing conducted under this section, the Board may employ any expert witnesses considered necessary to determine the competency and ability of the petitioner.  5. If the Board orders restoration of such certificate, it may waive the requirements of NRS 639.180, 639.190 and 639.2174.  (Added to NRS by 1975, 1306)
NV Rev Stat § 639.257 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.257 - Reinstatement of revoked certificate, license or permit.

  1. A person whose certificate, license or permit has been revoked may petition the Board for reinstatement after a period of not less than 1 year has lapsed since the date of revocation.  2. The petition shall state such facts as may be required by the Board and shall be heard by the Board at its next regular meeting held not earlier than 30 days after the petition is filed. Such petition may be considered by the Board while the petitioner is under sentence for any criminal offense, including any period during which the petitioner is on probation or parole, only if the Board members, by a majority vote, find that the public interest would best be served by such reinstatement.  3. In considering reinstatement the Board may investigate and consider all activities of the petitioner since the time the original certificate, license or permit was issued and his or her ability, character and reputation. The affirmative vote of at least three members is necessary for reinstatement of a certificate, license or permit with or without terms, conditions and restrictions.  (Added to NRS by 1967, 1661)
NV Rev Stat § 639.2575 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.2575 - Disciplinary action by hearing officer or panel: Procedural requirements; powers and duties of officer or panel; appeals.

  1. Any disciplinary action taken by a hearing officer or panel pursuant to NRS 639.081 is subject to the same procedural requirements which apply to disciplinary actions taken by the Board, and the officer or panel has those powers and duties given to the Board in relation thereto.  2. A decision of the hearing officer or panel relating to the imposition of a fine is a final decision in a contested case. Any party aggrieved by a decision of the officer or panel to place the holder of a certificate, license or permit on probation, reprimand him or her or revoke or suspend his or her certificate, license or permit may appeal that decision to the Board.  (Added to NRS by 1983, 1540)
NV Rev Stat § 639.2576 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.2576 - Immunity from civil action for assisting administrative proceeding.

The Board or any other person who initiates or assists in any lawful investigation or administrative proceeding concerning the discipline of a pharmacist is immune from any civil action for that initiation or assistance or any consequential damages, if the person acted without malicious intent.  (Added to NRS by 1987, 948)
NV Rev Stat § 639.258 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.258 - Filing of complaint.

Any person who becomes aware that a person practicing pharmacy in this State has, is or is about to become engaged in conduct which constitutes grounds for initiating disciplinary action may file a complaint with the Board. A complaint may be filed anonymously. If a complaint is filed anonymously, the Board may accept the complaint but may refuse to consider the complaint if anonymity of the complainant makes processing the complaint impossible or unfair to the person who is the subject of the complaint.  (Added to NRS by 2013, 2236)
NV Rev Stat § 639.2587 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.2587 - Name of manufacturer, packer or distributor of generic drug or interchangeable biological product to be noted on prescription; indication of substitution on label; exception.

If a generic drug or interchangeable biological product is substituted for a drug prescribed by brand name or biological product prescribed, the pharmacist or practitioner shall:  1. Note the name of the manufacturer, packer or distributor of the drug or biological product actually dispensed on the prescription; and  2. Indicate the substitution by writing or typing on the label the words "substituted for," or substantially similar language, following the generic name and preceding the brand name of the drug, or following the name of the interchangeable biological product and preceding the brand name of the prescribed biological product, as applicable, unless, at the time the initial substitution of the generic drug or interchangeable biological product for a drug prescribed by brand name or biological product prescribed is made, the person for whom the drug or interchangeable biological product is dispensed elects not to have such an indication written or typed on the label. An election to indicate or not to indicate a substitution on the label pursuant to this subsection applies to both the fill and each refill of the same prescription.  (Added to NRS by 1979, 1348; A 1985, 885; 1989, 1122; 1991, 1953; 2007, 658; 2013, 2899; 2017, 635)
NV Rev Stat § 639.2588 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.2588 - Manufacturer’s product identification code to be on certain dispensed tablets and capsules.

A pharmacist or practitioner shall not dispense by prescription any tablet or capsule, except one which is hypodermic, sublingual or soluble, if it does not have the manufacturer’s product identification code imprinted on it.  (Added to NRS by 1987, 1649; A 1989, 1122)
NV Rev Stat § 639.2589 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.2589 - Form for prescription required to contain line for practitioner’s signature; substitutions in filling prescriptions in certain facilities; substitutions in filling prescriptions ordered on patient’s chart in hospital.

  1. The form used for any prescription which is issued or intended to be filled in this state must contain a line for the signature of the practitioner.  2. Substitutions may be made in filling prescriptions contained in the orders of a physician, or of an advanced practice registered nurse who is a practitioner, in a facility for skilled nursing or facility for intermediate care.  3. Substitutions may be made in filling prescriptions for drugs ordered on a patient’s chart in a hospital if the hospital’s medical staff has approved a formulary for specific generic substitutions.  4. Substitutions may be made in filling prescriptions for biological products ordered on a patient’s chart in a hospital if the hospital’s medical staff has approved a formulary for specific interchangeable biological products.  (Added to NRS by 1979, 1348; A 1981, 393; 1983, 1511; 1985, 1769, 2005; 1991, 793; 2003, 1215; 2013, 2079; 2017, 636)
NV Rev Stat § 639.259 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.259 - Employer of pharmacist prohibited from requiring pharmacist to dispense specific generic drug or interchangeable biological product in certain circumstances.

No employer of a pharmacist may require the pharmacist to dispense any specific generic drug or interchangeable biological product in substitution for another drug or biological product if the:  1. Substitution is not permitted by the prescription as signed by a practitioner;  2. Substitution would be against the professional judgment of the pharmacist; or  3. Substitution would violate any provision of NRS 639.2583 to 639.2597, inclusive.  (Added to NRS by 1979, 1349; A 2003, 1215; 2017, 636)
NV Rev Stat § 639.2592 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.2592 - Dispensing pharmacist required to make record of dispensed biological product; recordation options; record deemed notice to prescriber; alternative types of notice; exceptions.

  1. Except as otherwise provided in subsections 3 and 4, within 3 business days after dispensing a biological product, the dispensing pharmacist or his or her designee shall make an entry of the specific product provided to the patient that includes, without limitation, the name of the product and its manufacturer. The record must be electronically accessible by the prescribing practitioner through:  (a) An interoperable electronic health records system;  (b) Electronic prescribing technology;  (c) A pharmacy benefit management system; or  (d) A pharmacy record.  2. An electronic record of the dispensing of a biological product made pursuant to subsection 1 is presumed to provide notice to the prescriber of the dispensing of the product.  3. Except as otherwise provided in subsection 4, if an electronic record of the dispensing of a biological product is not made pursuant to subsection 1, the dispensing pharmacist or his or her designee shall, within 3 business days after dispensing the biological product, give notice of the biological product to the prescriber by facsimile, telephone, electronic transmission or other available means.  4. Notice of the dispensing of a biological product pursuant to subsection 1 or 3 is not required if:  (a) There is no interchangeable biological product for the biological product prescribed; or  (b) A prescription for a refill is not changed from the product dispensed on the prior filling of the prescription.  5. As used in this section, "electronic health record" has the meaning ascribed to it in 42 U.S.C. § 17921(5).  (Added to NRS by 2017, 633)
NV Rev Stat § 639.2595 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.2595 - Liability of pharmacist or practitioner.

A pharmacist or practitioner who selects a drug or interchangeable biological product for substitution assumes no greater civil liability than he or she assumes by filling the prescription with the drug under its brand name or the prescribed biological product.  (Added to NRS by 1979, 1349; A 1989, 1122; 2017, 636)
NV Rev Stat § 639.2596 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.2596 - Board required to maintain link on Internet website to certain list of licensed biological products.

The Board shall maintain a link on its Internet website to the Purple Book: Lists of Licensed Biological Products with Reference Product Exclusivity and Biosimilarity or Interchangeability Evaluations, published by the Food and Drug Administration.  (Added to NRS by 2017, 633)
NV Rev Stat § 639.2597 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.2597 - Use of list of biologically equivalent drugs or interchangeable biological products.

A pharmacist or practitioner who proposes to make any substitution must have made use of a list of biologically equivalent drugs or interchangeable biological products approved by the United States Food and Drug Administration.  (Added to NRS by 1979, 1349; A 1989, 1122; 1993, 635; 2017, 636)
NV Rev Stat § 639.2627 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.2627 - Requirements for contents of and submission of collaborative practice agreement; expiration and renewal of agreement.

  1. A collaborative practice agreement must be signed by each practitioner and pharmacist who enter into the agreement and submitted to the Board in written and electronic form. A collaborative practice agreement must include:  (a) A description of the types of decisions concerning the management of drug therapy that the pharmacist is authorized to make, which may include a specific description of the diseases and drugs for which the pharmacist is authorized to manage drug therapy;  (b) A detailed explanation of the procedures that the pharmacist must follow when engaging in the collaborative practice of pharmacy, including, without limitation, the manner in which the pharmacist must document decisions concerning treatment and care in accordance with subsection 3 of NRS 639.2623, report such decisions to the practitioner and receive feedback from the practitioner;  (c) The procedure by which the pharmacist will notify the practitioner of an adverse event concerning the health of the patient;  (d) The procedure by which the practitioner will provide the pharmacist with a diagnosis of the patient and any other medical information necessary to carry out the patient’s drug therapy management;  (e) A description of the means by which the practitioner will monitor clinical outcomes of a patient and intercede when necessary to protect the health of the patient or accomplish the goals of the treatment prescribed for the patient;  (f) Authorization for the practitioner to override the agreement if necessary to protect the health of the patient or accomplish the goals of the treatment prescribed for the patient;  (g) Authorization for either party to terminate the agreement by written notice to the other party, which must include, without limitation, written notice to the patient that informs the patient of the procedures by which he or she may continue drug therapy;  (h) The effective date of the agreement;  (i) The date by which a review must be conducted pursuant to subsection 2 for the renewal of the agreement, which must not be later than the expiration date of the agreement;  (j) The address of the location where the records described in subsection 3 of NRS 639.2623 will be maintained; and  (k) The process by which the pharmacist will obtain the informed, written consent required by subsection 4 of NRS 639.2623.  2. A collaborative practice agreement must expire not later than 1 year after the date on which the agreement becomes effective. The parties to a collaborative practice agreement may renew the agreement after reviewing the agreement and making any necessary revisions.  (Added to NRS by 2017, 2520)
NV Rev Stat § 639.2629 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.2629 - Written guidelines and protocols authorizing collaborative drug therapy management: Authorized and required provisions; approval by Board; regulations.

  1. Written guidelines and protocols developed by a registered pharmacist in collaboration with a practitioner which authorize collaborative drug therapy management:  (a) May authorize a pharmacist to order and use the findings of laboratory tests and examinations.  (b) May provide for collaborative drug therapy management for a patient receiving care:  (1) In a licensed medical facility; or  (2) If developed to ensure continuity of care for a patient, in any setting that is affiliated with a medical facility where the patient is receiving care. A pharmacist who modifies a drug therapy of a patient receiving care in a setting that is affiliated with a medical facility shall, within 72 hours after initiating or modifying the drug therapy, provide written notice of the initiation or modification of the drug therapy to the collaborating practitioner or enter the appropriate information concerning the drug therapy in an electronic patient record system shared by the pharmacist and the collaborating practitioner.  (c) Must state the conditions under which a prescription of a practitioner relating to the drug therapy of a patient may be changed by the pharmacist without a subsequent prescription from the practitioner.  (d) Must be approved by the Board.  2. The Board may adopt regulations which:  (a) Prescribe additional requirements for written guidelines and protocols developed pursuant to this section; and  (b) Set forth the process for obtaining the approval of the Board of such written guidelines and protocols.  (Added to NRS by 2011, 3077; A 2017, 2522) — (Substituted in revision for NRS 639.2809)
NV Rev Stat § 639.263 (2021)
2021 Nevada Revised Statutes|Chapter 639 - Pharmacists and Pharmacy|NRS 639.263 - False or misleading advertising.

No registered pharmacist or owner of any pharmacy licensed under the provisions of this chapter may make, disseminate or cause to be made or disseminated before the public in this state, in any newspaper or other publication, or any advertising device, or in any other manner or means whatever, any statement concerning prices or services, professional or otherwise, which is untrue or misleading, and which is known, or which by the exercise of reasonable care should be known, to be false or misleading.  (Added to NRS by 1967, 1663)